Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 21, 2011
Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry
C E Teunissen, M J A Koel-Simmelink, T V Pham, et al.
Molecular & Cellular Proteomics : MCP
|
July 27, 2011
Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target
W J Van Houdt, B L Emmink, T V Pham, et al.
Oncogene
|
May 27, 2014
miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo
O Senol, T B M Schaaij-Visser, E P Erkan, et al.
British Journal of Cancer
|
September 26, 2013
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery
J Posthumadeboer, S R Piersma, T V Pham, et al.
Neuropathology and Applied Neurobiology
|
May 26, 2017
Brain endothelial cell expression of SPARCL-1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro
C Bridel, M J A Koel-Simmelink, L Peferoen, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 22, 2021
Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma
T Y S Le Large, M F Bijlsma, B El Hassouni, et al.
British Journal of Cancer
|
September 5, 2013
Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
N Snoeren, B L Emmink, M J G Koerkamp, et al.
Basic Research in Cardiology
|
June 19, 2025
The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotection
Y Xiao, X Hu, C F Rudolphi, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 21, 2011
Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry
C E Teunissen, M J A Koel-Simmelink, T V Pham, et al.
Molecular & Cellular Proteomics : MCP
|
July 27, 2011
Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target
W J Van Houdt, B L Emmink, T V Pham, et al.
Oncogene
|
May 27, 2014
miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo
O Senol, T B M Schaaij-Visser, E P Erkan, et al.
British Journal of Cancer
|
September 26, 2013
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery
J Posthumadeboer, S R Piersma, T V Pham, et al.
Neuropathology and Applied Neurobiology
|
May 26, 2017
Brain endothelial cell expression of SPARCL-1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro
C Bridel, M J A Koel-Simmelink, L Peferoen, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 22, 2021
Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma
T Y S Le Large, M F Bijlsma, B El Hassouni, et al.
British Journal of Cancer
|
September 5, 2013
Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
N Snoeren, B L Emmink, M J G Koerkamp, et al.
Basic Research in Cardiology
|
June 19, 2025
The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotection
Y Xiao, X Hu, C F Rudolphi, et al.
Page
of 2